2026 · 3rd Quarter (July 1 - Sep 30)

ABBOTT LABORATORIES

Filed by MARSHALL & POPP, LLC.

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Report
Posted: Oct 20, 2026
Income: $60,000.00
Expenses: Not reported
Registrant: MARSHALL & POPP, LLC
Client: ABBOTT LABORATORIES
Filing UUID: 3f21f9bb-de68-46fa-81eb-57bfad38d4ba
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

TAX · Taxation/Internal Revenue Code

H.R.3512/S.1821 - Tackling Predatory Litigation Funding Act.

Literal federal measure citations: H.R.3512, S.1821

DEF · Defense

Issues related to TRICARE coverage of diabetes management devices.

HCR · Health Issues

Proposals related to colorectal cancer screening.

TRD · Trade (domestic/foreign)

Proposals related to tariffs on products imported into the United States.

AGR · Agriculture

Issues related to infant formula, including H.R. 2300 - To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and S.4940 - Specialized Infant Formula Act.

Literal federal measure citations: H.R. 2300, S.4940

MMM · Medicare/Medicaid

Proposals related to Medicare coverage of continuous glucose monitors. Issues related to cancer diagnostics national coverage determination.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.